Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Mahmoud Zureik a National Institute of Health and Medical Research
(INSERM), Unit 408 Epidémiologie, Faculté de Médecine Xavier
Bichat, BP 416, 75870 Paris CEDEX 18, France, b National
Institute of Health and Medical Research (INSERM), Unit U454 Hôpital
Arnaud de Villeneuve, 34295 Montpellier Cedex 05, France Correspondence to:
Mahmoud Zureik zureik{at}vjf.inserm.fr
| |
Abstract |
|---|
|
|
|---|
Objective:
To assess whether the severity of asthma
is associated with sensitisation to airborne moulds rather than to other seasonal or perennial allergens.
Design:
Multicentre epidemiological survey in 30 centres.
Setting:
European Community respiratory health survey.
Participants:
1132 adults aged 20-44 years with
current asthma and with skin prick test results.
Main outcome measure:
Severity of asthma according to
score based on forced expiratory volume in one second, number of asthma
attacks, hospital admissions for breathing problems, and use of
corticosteroids in past 12 months.
Results:
The frequency of sensitisation to moulds
(Alternaria alternata or Cladosporium herbarum,
or both) increased significantly with increasing asthma severity (odds
ratio 2.34 (95% confidence interval 1.56 to 3.52) for either for
severe v mild asthma). This association existed in all of
the study areas (gathered into regions), although there were
differences in the frequency of sensitisation. There was no association
between asthma severity and sensitisation to pollens or cats.
Sensitisation to Dermatophagoides pteronyssinus was also
positively associated with severity. In multivariable logistic
regressions including sensitisation to moulds, pollens, D
pteronyssinus, and cats simultaneously, the odds ratios for sensitisation to moulds were 1.48 (0.97 to 2.26) for moderate v mild asthma and 2.16 (1.37 to 3.35) for severe
v mild asthma (P<0.001 for trend).
Conclusions:
Sensitisation to moulds is a powerful
risk factor for severe asthma in adults. This should be taken into account in primary prevention, management, and patients' education.
|
What is already known on this topic
It is unknown whether such sensitisation is generally associated with severity of asthma What this study adds
In this multicentre epidemiological survey, similar patterns of results were observed in various areas of the world |
| |
Introduction |
|---|
|
|
|---|
The severity of asthma varies widely between patients. Mild cases are characterised by normal lung function and patients are asymptomatic most of the time, whereas severe cases are characterised by permanently impaired lung function and frequent exacerbations. Little is known about the factors associated with severity, but the identification of such factors is necessary for management and prevention.
Sensitisation to airborne allergens might be involved in the underlying mechanisms of severity. The associations between exposure, sensitisation, and asthma have suggested that house dust mite, 1 2 animal dander, 3 4 cockroaches,5 pollens,6 and mould spores7 have a causal role in development. However, the associations between sensitisation to different allergens and the severity of asthma have been poorly explored.
Sensitisation to moulds has been suggested as a risk factor for life threatening asthma.8-10 However, the hypothesis that such sensitisation is generally associated with the severity of asthma remains to be investigated.
We used data from 1132 people with asthma from the entire dataset of
the European Community respiratory health survey to assess whether the
severity of asthma is associated with sensitisation to airborne moulds
rather than to other seasonal or perennial allergens.
| |
Methods |
|---|
|
|
|---|
The methods of the survey have been fully described elsewhere. 11 12 Briefly, participating centres randomly selected samples of 20 to 44 year olds, who completed a short postal questionnaire about asthma and asthma-like symptoms (stage 1). At stage 2 a random subsample of responders were invited to complete a more detailed questionnaire and undergo skin prick and blood tests, assessment of lung function by spirometry, and airway challenge with methacholine.
|
Standardised skin prick tests were carried out with allergen coated lancets (Phazets, Pharmacia Diagnostics, Uppsala, Sweden). The allergens selected in all centres were Alternaria alternata, Cladosporium herbarum, Phleum pratense (timothy grass), birch, olive, Parietaria judaica (pellitory-of-the-wall), common ragweed (Ambrosia artemisiifolia), Dermatophagoides pteronyssinus (house dust mite), and cat. An uncoated lancet was used as the negative control. Results were regarded as positive if the mean weal diameter was at least 3 mm larger than that for the negative control.
Figure 1 shows details of the study design and the numbers of participants involved at each stage.
Definitions of asthma and severity
Participants were defined as currently having asthma if they
answered yes to the question"Have you ever had asthma?"and if they
had had at least one asthma attack or had taken inhaled or oral
corticosteroids for asthma in the past 12 months. Asthma was classified
as mild, moderate, or severe according to a score derived from
Ronchetti et al.15 The overall total score ranged from 4 to 11, with levels of severity levels being mild (score 4 or 5),
moderate (6), or severe (
7).
| |
Results |
|---|
|
|
|---|
Of the 1132 people with asthma in this study, 564 (50%) had mild asthma, 333 (29%) had moderate asthma, and 235 (21%) had severe asthma. Severity was not related to age, sex, smoking, passive smoking, or parental history of asthma.
The proportion of people with mild asthma varied according to geographical area, ranging from 63% in southern Europe to 42% in Australia and New Zealand. The proportion with severe asthma was 15% in southern Europe, 17% in central Europe, 17% in northern Europe, 21% in the United Kingdom and Republic of Ireland, 28% in Australia and New Zealand, and 26% in Portland.
Over 73% of participants were sensitised to at least one allergen and 65% were sensitised to two or more. Sensitisation to moulds alone was extremely rare: nine people were sensitised to Alternaria only and two to Cladosporium only. The proportion of people with asthma with sensitisation to the various allergens varied according to the regions (table 1). Sensitisation to moulds was the lowest in southern Europe and the highest in Portland and in the United Kingdom and Republic of Ireland.
|
|
Table 2 shows that sensitisation to moulds was significantly associated with severity of asthma. For both Alternaria and Cladosporium the proportion of sensitised people increased with increasing severity (P<0.001 for trend). For Alternaria the odds ratio was 1.64 for moderate versus mild asthma and 2.05 for severe versus mild asthma. These remained unchanged in the multivariable models after we adjusted for possible confounding factors. For Cladosporium the odds ratio was >3 for severe versus mild asthma. When we considered sensitisation to either mould, the odds ratio was 2.34 for severe versus mild asthma (P<0.001). We observed similar patterns for the association between sensitisation to moulds and severity of asthma (severe versus mild asthma) in all regions (fig 2). We found no association between severity of asthma and sensitisation to pollens.
|
Severity of asthma was positively associated with sensitisation to D pteronyssinus but not with sensitisation to cats. To assess the independent relations between the various allergens and severity of asthma we carried out simultaneous logistic regressions including sensitisation to moulds, pollens, D pteronyssinus, and cats. For moulds (Alternaria or Cladosporium, or both) the odds ratios were 1.48 (0.97 to 2.26) for moderate versus mild asthma and 2.16 (1.37 to 3.35) for severe versus mild asthma (P<0.001 for trend).
The results were virtually identical when we included the number of
allergens the participants were sensitised to in the models.
| |
Discussion |
|---|
|
|
|---|
Our study of asthma from large population based samples of adults living in different countries showed that the severity of asthma is associated with sensitisation to Alternaria and Cladosporium but not to pollens. As expected the severity of asthma was also associated with sensitisation to D pteronyssinus.
Comparison with other studies
Previous studies have shown that sensitisation or exposure to
moulds is associated with death from asthma, life threatening
exacerbations,8-10 visits to emergency
departments,13 and admissions to hospital for
asthma,14 but this is the first population based study
that used criteria other than healthcare attendance alone to show that
sensitisation to moulds is a risk factor for severe asthma in adults.
To date, there has been little evidence that sensitisation to moulds is associated with severity of asthma. To our knowledge no population studies apart from the European Community respiratory health survey have investigated the association between severity of asthma and sensitisation to allergens in adults. In a study of the relative importance of sensitisation to individual allergens for bronchial hyper-responsiveness in the United Kingdom within the framework of the European survey, people with positive results to Cladosporium were considerably more responsive than those with positive results to cats or timothy grass.15 Analysis of Spanish data showed that sensitisation to Alternaria, cats, and timothy grass was associated with a decrease in forced expiratory volume in one second in women.16
We observed a differential association between moulds and pollens and severity of asthma. Possibly the size of fungal spores allows them to reach the lower airways and also they may be inhaled by means of fragments and other amorphous bioaerosols. Pollens are larger and their effect on asthma requires exceptional situations such as thunderstorms, when pollen is concentrated by changes in air flow, grains are ruptured by osmotic shock, and each grain releases hundreds of starch granules that are small enough to be respired.17 Other explanations for the different effects of sensitisation to moulds and to pollens are possible. Unlike pollens, moulds are present all through the year with increase in the spore counts during the autumn months. Also, the level of mould exposure is probably greater because the exposure occurs indoors rather than outdoors and people spend most of their time indoors. The severity of asthma was associated with sensitisation to airborne moulds despite the fact that sensitisation to moulds alone was extremely rare. This might suggest a synergistic or additive effect of various sensitisations in determining severity. However, this is unlikely because when the number of positive test results was taken into account in the analysis the results did not change.
Our results of the associations between moulds and severity of asthma may be put together with results from studies on asthma incidence or outbreaks, where the role of moulds can be suspected for effects that were primarily attributed to other allergens. Moulds might be involved in the dramatic increase in incidence in Tucson that was initially attributed in part to a 10-fold increase in atmospheric pollen due to the widespread use of ornamental trees that produce pollen.18 More recently, it has been suggested that moulds may have had a role in the asthma epidemics in Barcelona that were attributed to soybean.19
Conclusion
In conclusion, our results show that sensitisation to moulds might
be involved in the severity of asthma. Given the increase of asthma and
the prevalence of severe asthma in the past decades these results may
be relevant for many people. Those people with asthma who are
sensitised to airborne moulds should be educated to pay careful
attention to symptoms and comply with treatment, particularly during
the seasonal increase in mould spore counts. Patients should be
encouraged to decrease exposure by avoiding indoor conditions that
facilitate the growth of moulds
for example, by better ventilation and
by decreasing dampness.
| |
Acknowledgments |
|---|
Details of participating centres can be found with the long version of this paper on bmj.com
Contributions: See bmj.com
| |
Footnotes |
|---|
Funding: Australia: Allen & Hanbury, Australia; Belgium: Belgian Science Policy Office, National Fund for Scientific Research; France: Ministère de la Santé, Glaxo France, Institut Pneumologique d'Aquitaine, Contrat de Plan Etat-Région Languedoc-Roussillon, CNMATS, CNMRT (90MR/10, 91AF/6), Ministre délégué de la santé, RNSP, Ministère de l'Environnement (No 96115-EN96D4); Germany: GSF, Bundesminister für Forschung und Technologie, Bonn; Greece: Greek Secretary General of Research and Technology, Fisons, Astra, Boehringer-Ingelheim; India: Bombay Hospital Trust; Italy: Ministero dell'Univesità e della Ricerca Scientifica e Tecnologica, CNR, Regione Veneto Grant RSF No 381/05.93; New Zealand: Asthma Foundation of New Zealand, Lotteries Grant Board, Health Research Council of New Zealand; Norway: Norwegian Research Council project No 101422/310; Portugal: Glaxo Farmacêutica Lda, Sandoz Portugesa; Spain: Ministero Sanidad y Consumo FIS (grants 91/0016060/OOE-05E, 92/0319, 93/0393), Hospital General de Albacete, Hospital General Juan Ramón Jiménenz, Consejeria de Sanidad Principado de Asturias; Sweden: Swedish Medical Research Council, Swedish Heart Lung Foundation, Swedish Association against Asthma and Allergy, Swedish Society of Medicine, Astra, Glaxo-Wellcome, Boehringer-Ingelheim; Switzerland: Swiss National Science Foundation Grant 4026-28099; United Kingdom: National Asthma Campaign, British Lung Foundation, Department of Health, South Thames Regional Health Authority; United States: US Department of Health, Education and Welfare Public Health Service Grant No 2 S07 RR05521-28.
Competing interests: None declared.
The full version of this article
appears on bmj.com
| |
References |
|---|
|
|
|---|
| 1. | Sporik R, Holgate ST, Platts-Mills TAE, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990; 323: 502-507[Abstract]. |
| 2. | Peat JK, Tovey E, Toelle BG, Haby MM, Gray EJ, Mahmic A, et al. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996; 153: 141-146[Abstract]. |
| 3. | Ingram JM, Sporik R, Rose G, Honsinger R, Chapman MD, Platts-Mills TAE. Quantitative assessment of exposure to dog (Can f I) and cat (Fel d I) allergens: relation to sensitization and asthma among children living in Los Alamos, New Mexico. J Allergy Clin Immunol 1995; 96: 449-456[CrossRef][Web of Science][Medline]. |
| 4. | Sporik R, Ingram JM, Price W, Sussman JH, Honsinger RW, Platts-Mills TAE. Association of asthma with serum IgE and skin test reactivity to allergens among children living at high altitude. Tickling the dragon's breath. Am J Respir Crit Care Med 1995; 151: 1388-1392[Abstract]. |
| 5. |
Rosenstreich DL, Eggleston P, Kattan M, Baker D, Slavin RG, Gergen P, et al.
The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma.
N Engl J Med
1997;
336:
1356-1363 |
| 6. | Pollart SM, Reid MJ, Fling JA, Chapman MD, Platts-Mills TAE. Epidemiology of emergency room asthma in northern California: association with IgE antibody to ryegrass pollen. J Allergy Clin Immunol 1988; 82: 224-230[CrossRef][Web of Science][Medline]. |
| 7. | Halonen M, Stern DA, Wright AL, Taussig LM, Martinez FD. Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 1997; 155: 1356-1361[Abstract]. |
| 8. | O'Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O'Connell EJ, Ballard DJ, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991; 324: 359-363[Abstract]. |
| 9. | Black PN, Udy AA, Brodie SM. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000; 55: 501-504[CrossRef][Web of Science][Medline]. |
| 10. | Targonski PV, Persky VW, Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995; 95: 955-961[CrossRef][Web of Science][Medline]. |
| 11. | Burney PGJ, Luczynska C, Chinn S, Jarvis D. The European Community respiratory health survey. Eur Respir J 1994; 7: 954-960[Abstract]. |
| 12. | European Commission, Directorate General XII. Protocol for the European Community respiratory health survey. Luxembourg: Office for Official Publications, 1993 (L-2920). |
| 13. | Ross MA, Curtis L, Scheff PA, Hryhorczuk DO, Ramakrishnan V, Wadden RA, et al. Association of asthma symptoms and severity with indoor bioaerosols. Allergy 2000; 55: 705-711[CrossRef][Web of Science][Medline]. |
| 14. | Hopkinson L, O'Driscoll BR. Mould allergy is common in patients with severe asthma requiring multiple hospital admissions [abstract]. Eur Respir J 1997; 10 (suppl 25): 28S. |
| 15. |
Chinn S, Jarvis D, Luczynska C, Burney P.
Individual allergens as risk factors for bronchial responsiveness in young adults.
Thorax
1998;
53:
662-667 |
| 16. |
Sunyer J, Soriano J, Anto JM, Burgos F, Pereira A, Payo F, et al.
Sensitization to individual allergens as risk factors for lower FEV1 in young adults.
Int J Epidemiol
2000;
29:
125-130 |
| 17. | Newson R, Strachan K, Archibald E, Emberlin J, Hardaker P, Collier C. Effect of thunderstorms and airborne grass pollen on the incidence of acute asthma in England, 1990-94. Thorax 1997; 52: 680-685[Abstract]. |
| 18. | Sneller MR, Hayes HD, Pinnas JL. Frequency of airborne Alternaria spores in Tucson, Arizona over a 20-year period. Ann Allergy 1981; 46: 30-33[Web of Science][Medline]. |
| 19. | Codina R, Lockey RF. Possible role of molds as secondary etiologic agents of the asthma epidemics in Barcelona, Spain. J Allergy Clin Immunol 1998; 102: 318-320[CrossRef][Web of Science][Medline]. |
(Accepted 4 April 2002)
Read all Rapid Responses